A Review Of Patient-Reported Outcome Labels In The United States: January 2006-September 2013

Source: CRF Health

In this webinar, we go over background information on orphan drugs, priority and standard reviews,  PROs in rare diseases. Then, we analyze the results from reviewing product labels and drug approval packages (DAPs) for orphan drugs from January 2006. Our guest speaker is Ari Gnanasakthy.